封閉蛋白3(CLDN3)多克隆抗體
Polyclonal Antibody to Claudin 3 (CLDN3)
C7orf1; CPE-R2; CPETR2; HRVP1; RVP1; Clostridium Perfringens Enterotoxin Receptor 2; Ventral Prostate.1-Like Protein; CPE-Receptor 2
- 編號PAF293Mu02
- 物種Mus musculus (Mouse，小鼠) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 648 ¥ 1512 ¥ 2160 ¥ 5400 ¥ 21600
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對CLDN3的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別CLDN3。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學：5-20μg/mL;1:25-100
免疫細胞化學：5-20μg/mL;1:25-100
最佳稀釋倍數最終由用戶決定。
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Mus musculus (Mouse，小鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPF293Mu01 | 封閉蛋白3(CLDN3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPF293Mu02 | 封閉蛋白3(CLDN3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAF293Mu01 | 封閉蛋白3(CLDN3)多克隆抗體 | WB; IHC; ICC; IP. |
| PAF293Mu02 | 封閉蛋白3(CLDN3)多克隆抗體 | WB; IHC; ICC; IP. |
| LAF293Mu71 | 封閉蛋白3(CLDN3)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| SEF293Mu | 封閉蛋白3(CLDN3)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMF293Mu | 封閉蛋白3(CLDN3)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Eur J Appl Physiol | Gastrointestinal response and endotoxemia during intense exercise in hot and cool environments [Pubmed: 23314685] |
| European Journal of Applied Physiology | Effects of probiotics supplementation on gastrointestinal permeability, inflammation and exercise performance in the heat [Springer: Source] |
| Pediatr Crit Care Med | Clinical Characteristics Associated With Postoperative Intestinal Epithelial Barrier Dysfunction in Children With Congenital Heart Disease* [PubMed: 25162512] |
| Clinical Nutrition | Reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects: A randomized controlled trial: Arabinoxylans in gut barrier. [pubmed:28214040] |
| Clinics and Research in Hepatology and Gastroenterology | Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease [Pubmed: 31053499] |
| Nutrients | Intestinal Permeability in Children with Celiac Disease after the Administration of Oligofructose-Enriched Inulin into a Gluten-Free Diet—Results of a Randomized … [Pubmed: 32531982] |
| Journal of Exercise Physiology Online | Markers of Intestinal Damage in Individuals with and without Obesity during a 12-Week Exercise Period. [] |
| JACC: Basic to Translational Science | Dysbiosis and Intestinal Barrier Dysfunction in Pediatric Congenital Heart Disease is Exacerbated Following Cardiopulmonary Bypass [] |
| Nutrients | Short-Term Very High Carbohydrate Diet and Gut-Training Have Minor Effects on Gastrointestinal Status and Performance in Highly Trained Endurance Athletes [Pubmed:35565896] |
留言咨詢
